Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous glucose monitor maker’s facilities last year. In a filing with the ...

Dexcom received a warning letter on March 4 after the Food and Drug Administration found problems at facilities in Arizona and California, the company revealed Friday in a securities filing. Dexcom ...

(Reuters) -Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities, sending its ...

It’s a way for people to gain access to devices like the Dexcom that is intended to skip that rep tape often seen with pharmacies. Dexcom diabetes monitoring device facing national shortage ...

Products including Dexcom G6 (Dexcom, San Diego, California ... We overcame this using skin Tac adhesive and cut-out tape overpatches to secure the sensors in place and prevent removal. No ...

Kinesiology tape is a type of physical therapy treatment that can be used in many ways. It can help to improve muscular contractions, decrease swelling, and inhibit pain in injured tissues.

Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom (NASDAQ:DXCM). Patient monitoring companies within the healthcare equipment industry offer devices and ...

(COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in Southern Colorado frustrated. A Dexcom is responsible for ...

The Motley Fool recommends DexCom and recommends the following options ... And as far as them being unhappy with sticky tape or something not looking right? That really hasn't been that much ...

Analyst Price Forecast Suggests 14.60% Upside As of January 28, 2025, the average one-year price target for DexCom is $99.51/share. The forecasts range from a low of $75.75 to a high of $131.25.